flumazenil has been researched along with honokiol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuribara, H; Maruyama, Y; Stavinoha, WB | 1 |
| Chen, CR; Fan, K; Hou, YP; Huang, ZL; Qu, WM; Sun, Y; Urade, Y; Yue, XF | 1 |
2 other study(ies) available for flumazenil and honokiol
| Article | Year |
|---|---|
Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Bicuculline; Biphenyl Compounds; Caffeine; Central Nervous System Depressants; Central Nervous System Stimulants; Diazepam; Dose-Response Relationship, Drug; Flumazenil; GABA Antagonists; GABA Modulators; Injections, Subcutaneous; Lignans; Male; Maze Learning; Mice; Mice, Inbred BALB C; Motor Activity; Tetragastrin; Therapeutic Equivalency | 1998 |
Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABA(A) receptor in mice.
Topics: Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Flumazenil; GABA Modulators; Gene Expression; Injections, Intraperitoneal; Lignans; Male; Mice; Mice, Inbred C57BL; Patch-Clamp Techniques; Proto-Oncogene Proteins c-fos; Receptors, GABA-A; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Time Factors | 2012 |